Hi-Tech Pharmacal receives final approval for Lorazepam oral concentrate
Hi-Tech Pharmacal announced that the FDA granted final approval for the Company's Abbreviated New Drug Application for Lorazepam oral concentrate 2mg/mL, the generic for Roxanne’s Lorazepam Intensol® oral concentrate which had combined brand and generic sales of $10 million for the 12 months ended December 2011 according to IMS sales data. Hi-Tech plans to launch the product by May 2012. :theflyonthewall.com
News For HITK From The Last 14 Days
Check below for free stories on HITK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
